# To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms

> **NCT06158750** · NA · RECRUITING · sponsor: **Shanghai Wallaby Medical Technologies Co.,Inc.** · enrollment: 120 (estimated)

## Conditions studied

- Intracranial Aneurysm

## Interventions

- **DEVICE:** p64/p48 MW HPC Flow Modulation Device

## Key facts

- **NCT ID:** NCT06158750
- **Lead sponsor:** Shanghai Wallaby Medical Technologies Co.,Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-17
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-06-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06158750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06158750, "To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06158750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*